Cadrenal Therapeutics, Inc. share price logo

Cadrenal Therapeutics, Inc.

NASDAQ: CVKD

$0.99

+0.04

(+4.67%)

as on

Cadrenal Therapeutics, Inc. Stock Performance

as on October 7, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.90
    $1.05
    downward going graph

    9.09%

    Downside

    6.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.85
    $14.50
    downward going graph

    14.14%

    Downside

    1364.64%

    Upside

    downward going graph

Cadrenal Therapeutics, Inc. share price movements today

Previous Close
$0.95
Open
$0.96
Volume
313.4K
Market Cap
$3.4M
Day's Low - High
$0.90 - $1.05
52 Week Low - High
$0.85 - $14.50

Cadrenal Therapeutics, Inc. Historical Returns

1 Month Return
-18.85 %
3 Month Return
-68.67 %
1 Year Return
-92.73 %
3 Year Return
-89.57 %
5 Year Return
0 %

Cadrenal Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Cadrenal Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4M

EPS (TTM)

-4.9

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.19

Industry PE ratio

-3.01

PEG Ratio

-0.00

EBITDA

-11.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-406.38%

Cadrenal Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cadrenal Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$3.4MNA-0.190.00%0.00%
StrongBuy$44.5B617.67%-23.440.00%0.00%
Neutral$81.1B-39.40%-25.46-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B33.82%17.3584.86%0.51%

Stock Returns calculator for Cadrenal Therapeutics, Inc. Stock including INR - Dollar returns

The Cadrenal Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cadrenal Therapeutics, Inc. investment value today

Current value as on today

₹7,902

Returns

-₹92,098

(-92.1%)

Returns from Cadrenal Therapeutics, Inc. Stock

-₹92,729 (-92.73%)

Dollar Impact

₹631 (+0.63%)

Analyst Recommendation on Cadrenal Therapeutics, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Cadrenal Therapeutics, Inc.. Average target price of $14

Cadrenal Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Cadrenal Therapeutics, Inc..

What analysts predicted

92.93%UPSIDE

Target Price

$14

Current Price

$0.99

Analyzed by

1 Analysts

High

$13

Target

$14.00

Low

$13

Cadrenal Therapeutics, Inc. target price $14, a slight upside of 92.93% compared to current price of $0.99. According to 1 analysts rating.

Indian Investors' Interest in Cadrenal Therapeutics, Inc. Stock

Search interest for Cadrenal Therapeutics, Inc. Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-48% versus previous 30 day period

Cadrenal Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
-
0
0
-
Operating Income
-1
-1
-2
-2
-4
-3
-3
-2
-2
-3
EBITDA
-1
-1
-2
-2
-4
-3
-3
-2
-2
-3
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-2
-2
-4
-3
-3
-2
-2
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
-2
-2
-4
-3
-3
-2
-2
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cadrenal Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Mar 2026
Total Revenue
-
-
-
-
Gross Profit
0
-
0
-
Operating Income
-2
-7
-10
-13
EBITDA
-6
-8
-10
-13
Interest Expense
0
0
-
-
Depreciation
0
0
0
0
Income Before Tax
-6
-8
-10
-13
Income Tax Expense
-
-
-
-
Net Income
-6
-8
-10
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Cadrenal Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-1
-1
-2
-2
-4
-3
-3
-2
-2
-3
Operating Cash Flow
0
-1
-1
-2
-1
-4
-3
-2
-3
-2
Investing Cash Flow
-
-
-
-
0
0
-
0
-
0
Financing Cash Flow
0
0
-
1
7
1
1
0
1
2
Change in Cash
0
-1
-1
0
5
-2
-1
-1
-1
0

Cadrenal Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Mar 2026
Net Income
-7
-8
-10
-13
Operating Cash Flow
-1
-3
-7
-12
Investing Cash Flow
0
0
0
0
Financing Cash Flow
1
11
8
6
Change in Cash
0
8
1
-6

Global Institutional Holdings in Cadrenal Therapeutics, Inc.

Check out the Institutions with significant holdings in Cadrenal Therapeutics, Inc..

Funds
Holdings
Vanguard
1.41%
VANGUARD INDEX FUNDS
1.27%
Fidelity Concord Street Trust
0.38%
Dimensional
0.03%

Cadrenal Therapeutics, Inc. News & Key Events

  • img

    Today's Timeline - 31 August

    Mon, 06:28 PM

    -

    Cadrenal Therapeutics receives positive FDA feedback on CAD-1005 Phase 3 study protocol for heparin-induced thrombocytopenia.

Insights on Cadrenal Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 585.7% return, outperforming this stock by 678.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 80.5% return, outperforming this stock by 170.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CVKD stock has moved down by -8.3%

About Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
OrganisationCadrenal Therapeutics, Inc.
Headquarters822 A1A North, Ponte Vedra, FL, 32082, US
IndustryBiotechnology
CEOQuang X. Pham

Key Management of Cadrenal Therapeutics, Inc.

Name

Title

Mr. Jeffrey Cole

Chief Operating Officer

Mr. Quang X. Pham

Chairman & CEO

Mr. John P. Sharp CPA

Interim CFO & Principal Accounting Officer

FAQs

What is Cadrenal Therapeutics, Inc. share price today?

Cadrenal Therapeutics, Inc. share price today is $0.99 as on at the close of the market. Cadrenal Therapeutics, Inc. share today touched a day high of $1.05 and a low of $0.90.

What is the 52 week high and 52 week low for Cadrenal Therapeutics, Inc. share?

Cadrenal Therapeutics, Inc. share touched a 52 week high of $14.50 on and a 52 week low of $0.85 on . Cadrenal Therapeutics, Inc. stock price today i.e. is closed at $0.99,which is 93.17% down from its 52 week high and 16.47% up from its 52 week low.

What is Cadrenal Therapeutics, Inc.'s market capitalisation today?

Cadrenal Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Cadrenal Therapeutics, Inc. Stock (CVKD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cadrenal Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cadrenal Therapeutics, Inc. Stock (CVKD) from India?

Indian investors can start investing in Cadrenal Therapeutics, Inc. (CVKD) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in Cadrenal Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Cadrenal Therapeutics, Inc. share’s latest price of $0.99 as on October 7, 2026 at 8:45 am IST, you will get 10.1010 shares of Cadrenal Therapeutics, Inc.. Learn more about fractional shares .